Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-343
Closed -$20K 322
2022
Q3
$20K Sell
343
-15
-4% -$831 ﹤0.01% 420
2022
Q2
$17K Sell
358
-11
-3% -$576 ﹤0.01% 442
2022
Q1
$21K Hold
369
﹤0.01% 405
2021
Q4
$19K Hold
369
﹤0.01% 434
2021
Q3
$19K Buy
369
+15
+4% +$777 ﹤0.01% 418
2021
Q2
$21K Hold
354
﹤0.01% 392
2021
Q1
$23K Sell
354
-4
-1% -$246 ﹤0.01% 377
2020
Q4
$20K Buy
358
+12
+3% +$612 ﹤0.01% 383
2020
Q3
$15K Buy
346
+89
+35% +$3.91K ﹤0.01% 377
2020
Q2
$11K Sell
257
-530
-67% -$20.4K ﹤0.01% 418
2020
Q1
$31K Hold
787
0.01% 305
2019
Q4
$35K Sell
787
-169
-18% -$6.5K 0.01% 326
2019
Q3
$30K Buy
956
+169
+21% +$5.85K 0.01% 339
2019
Q2
$30K Hold
787
0.01% 336
2019
Q1
$24K Hold
787
﹤0.01% 351
2018
Q4
$22K Buy
+787
New +$21.6K ﹤0.01% 336

Other funds holding ACA

Howe & Rusling's ACA Position: Q4 2022 in Review

Howe & Rusling sold out of Arcosa (ACA) in Q4 2022, closing a stake of 343 shares — an estimated $20K sold.

Howe & Rusling first reported a position in ACA in Q4 2018 and held it in 16 quarters. The position peaked at $35K in Q4 2019. 267 funds tracked by Wall St. Rank hold ACA as of Q4 2022.

  • Howe & Rusling reported no remaining Arcosa position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 343 Arcosa shares in Q4 2022, an estimated $20K.
  • Howe & Rusling first reported a position in Arcosa in Q4 2018 and held it in 16 quarters.
  • Howe & Rusling's Arcosa position peaked at $35K in Q4 2019.
  • 267 funds tracked by Wall St. Rank held Arcosa as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.